{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T09:55:13Z","timestamp":1655373313718},"reference-count":26,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.3960\/jslrt.50.51","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T06:04:53Z","timestamp":1274853893000},"page":"51-58","source":"Crossref","is-referenced-by-count":3,"title":["Dic (17;20) (p11;q11) Preceded &lt;I&gt;MLL&lt;\/I&gt; Gene Amplification in a Patient with &lt;I&gt;de novo&lt;\/I&gt; Mixed-Lineage Leukemia"],"prefix":"10.3960","volume":"50","author":[{"given":"Ryuichi","family":"Amakawa","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Hiramoto","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hyo","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Nakamichi","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Tajima","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Ito","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Mori","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirou","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Kansai Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 WHO Classification of Tumours, Tumours of Haematopoietic and Lymphoid Tissues, Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. (eds) : 4th ed, Lyon, IARC, 2008"},{"key":"2","unstructured":"2 Soenen V, Preudhomme C, Roumier C, Daudignon A, La&iuml; JL, <I>et al<\/I>. : 17p deletion in acute myeloid leukaemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence <I>in situ<\/I>. Blood 91 : 1008-1015, 1998"},{"key":"3","unstructured":"3 Merlat A, La&iuml; JL, Sterkers Y, Demory JL, Bauters F, <I>et al<\/I>. : Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases. Leukemia 13 : 250-257, 1999"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, <I>et al<\/I>. : Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329 : 909-914, 1993","DOI":"10.1056\/NEJM199309233291302"},{"key":"5","unstructured":"5 Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, <I>et al<\/I>. : HRX involvement in <I>de novo<\/I> and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 81 : 3197-3203, 1993"},{"key":"6","unstructured":"6 Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G,, <I>et al<\/I>. : Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 7 : 1975-1986, 1993"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P : Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 86 : 3542-3552, 1995","DOI":"10.1182\/blood.V86.9.3542.bloodjournal8693542"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ayton PM, Cleary ML : Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20 : 5695-5707, 2001","DOI":"10.1038\/sj.onc.1204639"},{"key":"9","unstructured":"9 Streubel B, Valent P, Jager U, Edelhauser M, Wandt H, <I>et al<\/I>. : Amplification of the MLL gene on double minutes, a homogenous staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosomes Cancer 27 : 380-386, 2000"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Sait SN, Qadir MU, Conroy JM, Matsui S, Nowak NJ, <I>et al<\/I>. : Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome : identification of new amplification regions by fluorescence <I>in situ<\/I> hybridization and spectral karyotyping. Genes Chromosomes Cancer 34 : 42-47, 2002","DOI":"10.1002\/gcc.10038"},{"key":"11","unstructured":"11 Pajuelo-G&aacute;mez JC, Cervera J, Garc&#237;a-Casado Z, Mena-Dur&aacute;n AV, Valencia A, <I>et al<\/I>. : MLL amplification in acute myeloid leukemia. Cancer Genet Cytogenet 174 : 127-131, 2007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Andersen MK, Christiansen DH, Kirchhoff M, Pedersen-Bjergaard J : Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents. Genes Chromosomes Cancer 31 : 33-41, 2001","DOI":"10.1002\/gcc.1115"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Orita M, Suzuki Y, Sekiya T, Hayashi K : Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5 : 874-879, 1989","DOI":"10.1016\/0888-7543(89)90129-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, <I>et al<\/I>. : Chromosome 20 deletions in myeloid malignancies : reduction of the common deleted region, generation of a PAC\/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene 19 : 3902-3913, 2000","DOI":"10.1038\/sj.onc.1203728"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Watson N, Dunlop L, Robson L, Sharma P, Smith A : 17p- syndrome arising from a novel dicentric translocation in a patient with acute myeloid leukemia. Cancer Genet cytogenet 118 : 159-162, 2000","DOI":"10.1016\/S0165-4608(99)00188-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Patsouris C, Michael PM, Campbell LJ : A new nonrandom unbalanced t(17;20) in myeloid malignancies. Cancer Genet Cytogenet 138 : 32-37, 2002","DOI":"10.1016\/S0165-4608(02)00579-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Wang P, Spielberger RT, Thangavelu M, Zhao N, Davis EM, <I>et al<\/I>. : dic(5;17) : a recurring abnormality in malignant myeloid disorders associated with mutations of TP53. Genes Chromosomes Cancer 20 : 282-291, 1997","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<282::AID-GCC9>3.0.CO;2-Z"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Castro PD, Liang JC, Nagarajan L : Deletions of chromosome 5q13.3 and 17p loci in myeloid neoplasms. Blood 95 : 2138-2143, 2000","DOI":"10.1182\/blood.V95.6.2138"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, <I>et al<\/I>. : Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 14 : 796-804, 2000","DOI":"10.1038\/sj.leu.2401773"},{"key":"20","unstructured":"20 Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, <I>et al<\/I>. : Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 58 : 55-59, 1998"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Ariyama Y, Fukuda Y, Okuno Y, Seto M, Date K, <I>et al<\/I>. : Amplification on double-minute chromosomes and partial-tandem duplication of the MLL gene in leukemic cells of a patient with acute myelogenous leukemia. Genes Chromosomes Cancer 23 : 267-272, 1998","DOI":"10.1002\/(SICI)1098-2264(199811)23:3<267::AID-GCC10>3.0.CO;2-J"},{"key":"22","unstructured":"22 Lochner K, Siegler G, Fuhrer M, Greil J, Beck JD, <I>et al<\/I>. : A specific deletion in the breakpoint cluster region of the ALL-1 gene is associated with acute lymphoblastic T-cell leukemias. Cancer Res 56 : 2171-2177, 1996"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Streubel B, Valent P, Jager U, Edelhauser M, Wandt H, <I>et al<\/I>. : Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosomes Cancer 27 : 380-386, 2000","DOI":"10.1002\/(SICI)1098-2264(200004)27:4<380::AID-GCC7>3.0.CO;2-#"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Cuthbert G, Thompson K, McCullough S, Watmore A, Dickinson H, <I>et al<\/I>. : MLL amplification in acute leukaemia : a United Kingdom Cancer Cytogenetics Group (UKCCG) study. Leukemia 14 : 1885-1891, 2000","DOI":"10.1038\/sj.leu.2401919"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Poppe B, Vandesompele J, Schoch C, Lindvall C, Mrozek K, <I>et al<\/I>. : Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 103 : 229-235, 2004","DOI":"10.1182\/blood-2003-06-2163"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Zatkova A, Merk S, Wendehack M, Bilban M, Muzik EM, <I>et al<\/I>. : AML\/MDS with 11q\/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes. Genes Chromosomes Cancer 48 : 510-520, 2009","DOI":"10.1002\/gcc.20658"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/50\/1\/50_1_51\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T01:46:19Z","timestamp":1591321579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/50\/1\/50_1_51\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.50.51","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}